GLP-1 medicines can reduce appetite, but your body still needs enough energy and nutrients to function well
What's underlying the fight, says Robin Feldman, a law professor at the University of California, is "the inordinate amount of money that is changing hands for the new weight-loss drugs, their incredible efficacy, the runaway demand
Los cambios en el estilo de vida son siempre la base para mantener un peso saludable
Why it happens: Body prioritizes essential functions during caloric deficit
They decide how much to charge and keep control for years
Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) activate these receptors at a sustained level throughout the day